Technical Competitive Advantage: RMB’s deep material and product development expertise position the company as a value-added partner to its customers. Thus, the company is not vulnerable to low cost country sourcing and domestic competition.

New Market Opportunities: At the time of investment, RMB had underpenetrated the commercial aerospace market and had significant, yet unrealized potential with a biopharmaceutical application.

Favorable Aerospace Trends and Opportunities: In 2010, the commercial and military aerospace industry was undergoing a dramatic evolution, replacing significant amounts of alloy components with lighter weight composites and plastics. RMB was poised to supply these specialty materials to major players in the industry.

Proprietary Products: RMB is the sole source resin supplier for all rotationally molded aviation HVAC ducting. The company’s proprietary resin was formulated to meet Federal Aviation Regulation smoke and fire standards governing commercial aerospace applications.

Entered Biopharma Market: Partnered with well known industry leaders to develop and commercialize highly engineered container for biopharmaceutical products.

Drove Outsized Growth in Aerospace: The Company’s commercial aerospace market share has more than tripled after shifting focus from calling on OEMs to Tier 1 manufacturers.

Capabilities Expansion: Replaced 6 existing 3D printing cells with state-of-the-art 3D printing equipment, gaining 50% throughput while dramatically lowering cost. Invested in unique rotational molding equipment and built out a clean room to serve the biopharma and semiconductor markets.

Strengthened Management Team: Recruited several talented business development and financial professionals to complement existing organization .

Digital Marketing Overhaul: Launched new website focused on lead generation and continuously publishing content around company’s unique capabilities and how they are utilized in target markets.